The stock of cannabis company Tilray, a subsidiary of Seattle-based Privateer Holdings, climbed 5.3 percent Wednesday on news of the deal.
Cannabis company Tilray is acquiring a Manitoba hemp-food manufacturer for up to $316 million ($419 million Canadian), tapping into its extensive U.S. distribution network and an upcoming line of CBD products.
Manitoba Harvest sells hemp-based granola, protein powder, milk and other food products at more than 13,000 points of sale across the U.S., including Walmart, Costco Wholesale, CVS Health, Kroger and online at Amazon.
The closely held company also plans to launch a line of products containing CBD, the popular nonintoxicating compound found in hemp and cannabis, this summer. Proponents argue cannabidiol, the formal name for CBD, can help with everything from arthritis to insomnia, and retailers are watching the growing demand with interest.
“Retailers are seeing hemp mania, it’s one of the fastest-growing products right now,” said Bill Chiasson, chief executive officer of the Winnipeg-based company. “All of them are looking at bringing on products that contain CBD into their portfolio and every one of them has come to us and said they see us as a natural partner.”
Most Read Business Stories
- Flawed analysis, failed oversight: How Boeing, FAA certified the suspect 737 MAX flight control system | Times Watchdog
- Boeing has 737 MAX software fix ready for airlines as DOT launches new scrutiny of entire FAA certification process
- Belltown penthouse is region’s priciest condo sale ever — and new owners won't even live there
- Amazon finds an alternative workforce through Northwest Center, a Seattle nonprofit helping people with disabilities
- Boeing defends 737 MAX's cockpit add-ons, begins new pilot information sessions
Shares of Nanaimo, B. C-based Tilray, a subsidiary of Seattle-based Privateer Holdings, climbed 5.3 percent Wednesday to $81.10. The shares have gained 15 percent so far this year.
However, CBD’s legal status remains somewhat opaque in the U.S. While Congress passed a farm bill in December that made hemp and its compounds, including CBD, legal under certain circumstances, the Food and Drug Administration has said it’s illegal to market the products as dietary supplements. Some jurisdictions, including New York City, have been cracking down on sales. In Canada, CBD-infused food and beverages won’t be legal until later this year.
The deal, announced Wednesday, will see Tilray pay C$277.5 million in cash and stock up front and an additional C$92.5 million six months after closing. It will issue another C$49 million in Tilray shares to Manitoba Harvest based on the company achieving certain financial milestones in 2019.
Manitoba Harvest posted C$94 million in gross revenue in 2018. Tilray, the second-biggest cannabis company by market value, is expected to report revenue of $40 million for the full year when it reports results March 18, according to the average of five analyst estimates compiled by Bloomberg.
“When we looked at Manitoba Harvest we saw a trusted brand with a multinational supply chain,” said Tilray CEO Brendan Kennedy. “That was extremely appealing.” Manitoba Harvest’s Canadian farmers jointly grow up to 30,000 acres of hemp and the company has two manufacturing facilities, in Winnipeg and Ste. Agathe, Manitoba.
“We think that supply chain is going to be a valuable asset as we look to the future of the cannabis industry,” he said.
It’s currently illegal to transport CBD across the Canada-U. S. border, so Tilray is looking closely at developing hemp-processing facilities in the U.S., Kennedy said.
“It’s very likely that we will deploy capital in the U.S. to take advantage of the opportunities presented through the farm bill at some point in the next 12 months,” he said. “This is an important first step.”